Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
lanreotide
×
NET
×
1 year
×
Clear all
Filters
3
NCT05477576
2026-01-20
ACTION-1
RayzeBio, Inc.
Phase 3
Recruiting
288 enrolled
NCT06878664
2025-09-02
RIALTO
Grupo Espanol de Tumores Neuroendocrinos
Phase 3
Recruiting
166 enrolled